论文部分内容阅读
目的:探讨联合检测血清H-FABP、P选择素检测对急性心肌梗死近期预后的评估。方法:将123例急性心肌梗死分成不良心血管事件(MACE)组(44例)和非MACE组(79例),比较两组血浆H-FABP、P选择素浓度。结果:MACE组血清H-FABP为(68.53±32.57)ng/L、P选择素为(353.21±88.17)ng/L,均高于非MACE组的(47.58±21.56)ng/L、(286.21±76.35)ng/L(均P<0.05)。结论:血浆H-FABP、P选择素对急性心肌梗死患者发生不良心血管事件具有较好的预警作用。
Objective: To explore the combined detection of serum H-FABP, P-selectin in the assessment of the short-term prognosis of acute myocardial infarction. Methods: 123 cases of acute myocardial infarction were divided into two groups: MACE group (44 cases) and non-MACE group (79 cases). Plasma H-FABP and P-selectin concentrations were compared between two groups. Results: The serum H-FABP in MACE group was (68.53 ± 32.57) ng / L and P-selectin was (353.21 ± 88.17) ng / L higher than that in non-MACE group (47.58 ± 21.56) ng / L, 76.35) ng / L (all P <0.05). Conclusion: Plasma H-FABP and P-selectin have a good early warning effect on adverse cardiovascular events in patients with acute myocardial infarction.